Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons

Abstract

The instant invention involves the use of a combination of preparatory steps in conjunction with mass spectroscopy and time-of-flight detection procedures to maximize the diversity of biopolymers which are verifiable within a particular sample. The cohort of biopolymers verified within such a sample is then viewed with reference to their ability to evidence at least one particular disease state; thereby enabling a diagnostician to gain the ability to characterize either the presence or absence of said at least one disease state relative to recognition of the presence and/or the absence of said biopolymer.

1 . A biopolymer marker having the sequence ID GDFLAEGGGVR useful in indicating at least one particular disease state.  
     
     
         2 . The biopolymer marker of  claim 1  wherein said disease state is myocardial infarction.